These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8129493)

  • 21. Psychological counseling strategies for women at risk of breast cancer.
    Kash KM; Holland JC; Osborne MP; Miller DG
    J Natl Cancer Inst Monogr; 1995; (17):73-9. PubMed ID: 8573459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer genetic risk assessment for individuals at risk of familial breast cancer.
    Guirguis-Blake J
    Am Fam Physician; 2008 Feb; 77(4):449-50. PubMed ID: 18326163
    [No Abstract]   [Full Text] [Related]  

  • 23. Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer.
    Forman AD; Hall MJ
    Breast J; 2009; 15 Suppl 1():S56-62. PubMed ID: 19775331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.
    Di Prospero LS; Seminsky M; Honeyford J; Doan B; Franssen E; Meschino W; Chart P; Warner E
    CMAJ; 2001 Apr; 164(7):1005-9. PubMed ID: 11314429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coping with genetic testing for breast cancer susceptibility.
    Dougall AL; Smith AW; Somers TJ; Posluszny DM; Rubinstein WS; Baum A
    Psychosom Med; 2009 Jan; 71(1):98-105. PubMed ID: 19124622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of genetic testing for cancer susceptibility in gynecologic practice.
    Karlan BY; Berchuck A; Mutch D
    Obstet Gynecol; 2007 Jul; 110(1):155-67. PubMed ID: 17601911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous interdisciplinary counseling in German breast/ovarian cancer families: first experiences with patient perceptions, surveillance behavior and acceptance of genetic testing.
    Hofferbert S; Worringen U; Backe J; Rückert EM; White K; Faller H; Grimm T; Caffier H; Chang-Claude J; Weber BH
    Genet Couns; 2000; 11(2):127-46. PubMed ID: 10893664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result.
    Bonadona V; Saltel P; Desseigne F; Mignotte H; Saurin JC; Wang Q; Sinilnikova O; Giraud S; Freyer G; Plauchu H; Puisieux A; Lasset C
    Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):97-104. PubMed ID: 11815406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic testing for breast and ovarian cancer susceptibility: a family experience.
    Van Riper M; McKinnon WC
    J Midwifery Womens Health; 2004; 49(3):210-9. PubMed ID: 15134674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing.
    Lodder L; Frets PG; Trijsburg RW; Tibben A; Meijers-Heijboer EJ; Duivenvoorden HJ; Wagner A; van Der Meer CA; Devilee P; Cornelisse CJ; Niermeijer MF
    Eur J Hum Genet; 2001 Jul; 9(7):492-500. PubMed ID: 11464240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
    Chompret A
    J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Psychosocial factors associated with genetic testing for certain hereditary types of neoplasms].
    Franková V; Zidovská J; Krutílková V; Havlovicová M; Goetz P
    Cas Lek Cesk; 2003; 142(10):599-602. PubMed ID: 14635423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family study.
    Lynch HT; Watson P; Conway TA; Lynch JF; Slominski-Caster SM; Narod SA; Feunteun J; Lenoir G
    Arch Intern Med; 1993 Sep; 153(17):1979-87. PubMed ID: 8357282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using genetic analysis to individualize preventive measures for breast and ovarian cancers.
    Olopade OI
    Nat Clin Pract Oncol; 2006 Apr; 3(4):182-3. PubMed ID: 16596140
    [No Abstract]   [Full Text] [Related]  

  • 35. Patients' resistance to risk information in genetic counseling for BRCA1/2.
    Gurmankin AD; Domchek S; Stopfer J; Fels C; Armstrong K
    Arch Intern Med; 2005 Mar; 165(5):523-9. PubMed ID: 15767527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic testing for cancer risk: research projects being funded.
    Oncology (Williston Park); 1994 Dec; 8(12):16-8. PubMed ID: 7888308
    [No Abstract]   [Full Text] [Related]  

  • 37. What price screening?
    Warshaw LJ
    Hastings Cent Rep; 1994; 24(5):46. PubMed ID: 8002313
    [No Abstract]   [Full Text] [Related]  

  • 38. Foreword.
    Ashley SW
    Curr Probl Surg; 2010 Oct; 47(10):742. PubMed ID: 20816138
    [No Abstract]   [Full Text] [Related]  

  • 39. Psychological opportunities and hazards in predictive genetic testing for cancer risk.
    Codori AM
    Gastroenterol Clin North Am; 1997 Mar; 26(1):19-39. PubMed ID: 9119438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stress and genetic testing for disease risk.
    Baum A; Friedman AL; Zakowski SG
    Health Psychol; 1997 Jan; 16(1):8-19. PubMed ID: 9028812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.